← Back to Search

Behavioral Intervention

Smoking Cessation Program for Sexual and Gender Minority Young Adults

N/A

Waitlist Available

Led By Jaimee Heffner

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Self-identify being between 18 and 30 years of age

Participants must be willing to use the assigned intervention program, complete the study assessments, and agree to the online consent form in English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new smoking cessation program called EQQUAL-NM, designed for young adults who are part of the sexual and gender minority community in New Mexico. This group has a higher rate of

Who is the study for?

This trial is for sexual and gender minority young adults in New Mexico who smoke and are interested in quitting. It's designed to help this group because they have higher smoking rates than non-SGM adults.

What is being tested?

The EQQUAL-NM program, a smartphone app-based smoking cessation intervention tailored for SGM young adult smokers, is being tested. Participants will also provide biospecimens, answer questionnaires, and receive health education.

What are the potential side effects?

Since the intervention involves a smartphone app and educational materials rather than medication or medical procedures, no direct side effects are expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 30 years old.

Select...

I am willing to follow the study plan, complete all checks, and agree to the consent form in English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of logins to the assigned application

Participant satisfaction

Secondary study objectives

Biochemically confirmed 30-day PPA from all nicotine/tobacco products

Biochemically confirmed 7-day point prevalence abstinence (PPA) from all nicotine/tobacco products

Change in Contemplation Ladder scores

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (EQQUAL-NM, Program A)Experimental Treatment4 Interventions

Participants receive self-guided smartphone app-delivered EQQUAL-NM (Program A) intervention on study. Participants also receive motivational messages, reminders and smoking cessation information via text messages. Some participants also complete at-home saliva sample collection during follow-up.

Group II: Arm II (EQQUAL-NM, Program B)Active Control4 Interventions

Participants receive self-guided smartphone app-delivered EQQUAL-NM (Program B) intervention on study. Participants also receive motivational messages, reminders and smoking cessation information via text messages. Some participants also complete at-home saliva sample collection during follow-up.

0 / 2Eligibility criteria met